CollPlant Biotechnologies (CLGN) Work In Process (2022 - 2025)

CollPlant Biotechnologies has reported Work In Process for 4 years, with the latest figure at $283000.0 in Q4 2025.

• For the quarter ending Q4 2025, Work In Process fell 1.05% year-over-year to $283000.0; the trailing twelve-month figure through Dec 2025 stood at $283000.0 (down 1.05% YoY), and the FY2025 full-year result was $283000.0, down 1.05% from the prior year.
• Work In Process for Q4 2025 stood at $283000.0, down from $286000.0 in the prior quarter.
• The five-year high for Work In Process was $881000.0 in Q4 2022, with the low at $173000.0 in Q4 2023.
• Historically, Work In Process has averaged $405750.0 across 4 years, with a median of $284500.0 in 2024.
• Annual changes were most pronounced in 2023 — Work In Process plunged 80.36% — and 2024, when it soared 65.32%.
• CollPlant Biotechnologies' Work In Process stood at $881000.0 in 2022, then sank by 80.36% to $173000.0 in 2023, then soared by 65.32% to $286000.0 in 2024, then retreated by 1.05% to $283000.0 in 2025.
• The last three Work In Process figures came in at $283000.0 (Q4 2025), $286000.0 (Q4 2024), and $173000.0 (Q4 2023), per Business Quant data.